Serum 25-hydroxy Vitamin D Status is Not Related to Osteopenia/Osteoporosis Risk in Colorectal Cancer Survivors |
Akinci, Muhammed Bulent
(Department of Medical Oncology, Yildirim Beyazit University)
Sendur, Mehmet Ali Nahit (Department of Medical Oncology, Ankara Numune Education and Research Hospital) Aksoy, Sercan (Department of Medical Oncology, Hacettepe University Institute of Oncology) Yazici, Ozan (Department of Medical Oncology, Ankara Numune Education and Research Hospital) Ozdemir, Nuriye Yildirim (Department of Medical Oncology, Yildirim Beyazit University) Kos, Tugba (Department of Medical Oncology, Ankara Numune Education and Research Hospital) Yaman, Sebnem (Department of Medical Oncology, Ankara Numune Education and Research Hospital) Altundag, Kadri (Department of Medical Oncology, Hacettepe University Institute of Oncology) Zengin, Nurullah (Department of Medical Oncology, Ankara Numune Education and Research Hospital) |
1 | Siegel R, Ward E, Brawley O, Jemal A (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 61, 212-36. DOI |
2 | Ng K, Wolpin BM, Meyerhardt JA, et al (2009). Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer, 101, 916-23. DOI ScienceOn |
3 | Perez EA, Josse RG, Pritchard KI, et al (2006). Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17. J Clin Oncol, 24, 3629-35. DOI ScienceOn |
4 | Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. DOI ScienceOn |
5 | Trump DL, Deeb KK, Johnson CS (2010). Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy. Cancer J, 16, 1-9. DOI ScienceOn |
6 | Wu K, Feskanich D, Fuchs CS, et al (2007). A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst, 99, 1120-9. DOI ScienceOn |
7 | Ma Y, Yu WD, Hershberger PA, et al (2008). 1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model. Mol Cancer Ther, 7, 3047-55. DOI ScienceOn |
8 | Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008). FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int, 19, 385-97. DOI ScienceOn |
9 | Lee JE, Li H, Chan AT, et al (2011). Circulating levels of vitamin D and colon and rectal cancer: the Physicians’ Health Study and a meta-analysis of prospective studies. Cancer Prev Res, 4, 735-43. DOI ScienceOn |
10 | Lonning PE, Geisler J, Krag LE, et al (2005). Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer. J Clin Oncol, 23, 5126-37. DOI ScienceOn |
11 | Ma Y, Zhang P, Wang F, et al (2011). Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol, 29, 3775-82. DOI ScienceOn |
12 | Maddipatla S, Tan W, Wilding GE, et al (2007). Vitamin D status in patients with colorectal cancer. 2007 Gastrointestinal Cancers Symposium Abstract 260. |
13 | Moffatt KA, Johannes WU, Miller GJ (1999). 1Alpha, 25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines. Clin Cancer Res, 5, 695-703. |
14 | Ng K, Meyerhardt JA, Wu K, et al (2008). Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol, 26, 2984-91. DOI ScienceOn |
15 | Ng K, Sargent DJ, Goldberg RM, et al (2011). Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol, 29, 1599-606. DOI ScienceOn |
16 | Garland CF, Garland FC, Gorham ED, et al (2006). The role of vitamin D in cancer prevention. Am J Public Health, 96, 252-61. DOI ScienceOn |
17 | Giovannucci E, Liu Y, Rimm EB, et al (2006). Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst, 98, 451-9. DOI ScienceOn |
18 | Fakih MG, Trump DL, Johnson CS, et al (2009). Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Colorectal Dis, 24, 219-24. DOI |
19 | Feskanich D, Ma J, Fuchs CS, et al (2004). Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev, 13, 1502-8. |
20 | Gorham ED, Garland CF, Garland FC, et al (2005). Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol, 97, 179-94. DOI ScienceOn |
21 | Gorham ED, Garland CF, Garland FC, et al (2007). Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med, 32, 210-6. DOI ScienceOn |
22 | Hershberger PA, Yu WD, Modzelewski RA, et al (2001). Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. Clin Cancer Res, 7, 1043-51. |
23 | Holick MF (2007). Vitamin D deficiency. N Engl J Med, 357, 266-81. DOI ScienceOn |
24 | Jenab M, Bueno-de-Mesquita HB, Ferrari P, et al (2010). Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ, 340, 5500. DOI |
25 | Boyce SP, Mincey BA, Duh M, et al (2005). Risk of osteoporosis/osteopenia among women with breast cancer receivin anticancer theapy (ACT). J Clin Oncol, 23, 665. DOI ScienceOn |
26 | Kanis JA (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int, 4, 368-81. DOI ScienceOn |
27 | Deeb KK, Trump DL, Johnson CS (2007). Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer, 7, 684-700. DOI ScienceOn |
28 | Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006). Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr, 84, 18-28. |
29 | Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA (2011). Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the US Preventive Services Task Force. Ann Intern Med, 155, 827-38. DOI ScienceOn |
30 | Eastell R, Adams JE, Coleman RE, et al (2008). Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. J Clin Oncol, 26, 1051-7. DOI ScienceOn |
![]() |